A comparison of rt-PA thrombolysis guidelines between China and the USA: Are changes needed?

Neurological Research

Volumn 37, Issue 1, 2015, Pages 57-63

  Xu, Jing ^a   Zhang, Yongjin ^a   Wei, Hongyu ^b   Xu, Yan ^a   Wang, Min ^a   Cai, Zenglin ^a   Li, Xiaomin ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b The Second People s Hospital of Lianyungang   (China)

Author keywords

Acute ischemic stroke (AIS); Alteplase); Intravenous thrombolysis; Meta analysis; Recombinant tissue plasminogen activator (rt PA

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; AWARENESS; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHINA; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; META ANALYSIS; MORTALITY; PRACTICE GUIDELINE; REGRESSION ANALYSIS; SMOKING; SYSTEMATIC REVIEW; TIME TO TREATMENT; UNITED STATES; STROKE;

BRAIN ISCHEMIA; CHINA; FIBRINOLYTIC AGENTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RECOMBINANT PROTEINS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; UNITED STATES;

EID: 84919330279     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132814Y.0000000415     Document Type: Article

References (37)

1. Molina CA, Alvarez-Sabin J. Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis. 2009;27(Suppl 1):162-7.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-7.
3. Reeves MJ, Arora S, Broderick JP, Frankel M, Heinrich JP, Hickenbottom S, et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke. 2005;36:1232-40.
4. Wang Y, Liao X, Zhao X, Wang DZ, Wang C, Nguyen-Huynh MN, et al. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the ChineseNational Stroke Registry (CNSR). Stroke. 2011;42:1658-64.
5. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke. 2000;31:1812-6.
6. Chiu D, Krieger D, Villar-Cordova C, Kasner SE, Morgenstern LB, Bratina PL, et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. Stroke. 1998;29:18-22.
7. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC. Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke. 2000;31:77-81.
8. Tanne D, Gorman MJ, Bates VE, Kasner SE, Scott P, Verro P, et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience. Stroke. 2000;31:370-5.
9. Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke. 2003;34:695-8.
10. Merino JG, Latour LL, Todd JW, Luby M, Schellinger PD, Kang DW, et al. Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders. Stroke. 2007;38:2919-23.
11. Tsivgoulis G, Saqqur M, Sharma VK, Lao AY, Hill MD, Alexandrov AV. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. Stroke. 2007;38:961-6.
12. Scott PA, Frederiksen SM, Kalbfleisch JD, Xu Z, Meurer WJ, Caveney AF, et al. Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams. Acad Emerg Med. 2010;17:1062-71.
13. LaMonte MP, Bahouth MN, Magder LS, Alcorta RL, Bass RR, Browne BJ, et al. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial. Ann Emerg Med. 2009;54:319-27.
14. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002;59:862-7.
15. Akins PT, Delemos C, Wentworth D, Byer J, Schorer SJ, Atkinson RP. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke. Neurology. 2000;55:1801-5.
16. Egan R, Lutsep HL, Clark WM, Quinn J, Kearns K, Lockfeld A, et al. Open label tissue plasminogen activator for stroke: the Oregon experience. J Stroke Cerebrovasc Dis. 1999;8:287-90.
17. Mateen FJ, Nasser M, Spencer BR, Freeman WD, Shuaib A, Demaerschalk BM, et al. Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc. 2009;84:334-8.
18. Pervez MA, Silva G, Masrur S, Betensky RA, Furie KL, Hidalgo R, et al. Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe. Stroke. 2010;41:e18-24.
19. Asimos AW, Norton HJ, Price MF, Cheek WM. Therapeutic yield and outcomes of a community teaching hospital code stroke protocol. Acad Emerg Med. 2004;11:361-70.
20. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283:1151-8.
21. Hassan AE, Hassanzadeh B, Tohidi V, Kirmani JF. Very mild stroke patients benefit from intravenous tissue plasminogen activator without increase of intracranial hemorrhage. South Med J. 2010;103:398-402.
22. Zhang B, Sun XJ, Ju CH. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke. Eur Neurol. 2011;65:170-4.
23. Zhang YD. Study of individualized treatment under the guide of perfusion MR in the patients with infarction within 9 hours of symptom onset [dissertation]. Fuzhou: Fujian Medical University; 2008.
24. Jing FY, Zhang ZC. The observation of rt-PA thrombolytic therapy in 60 cases with ultra-early acute cerebral infarction. J Apoplexy Nerv Dis. 2010;27:745-6.
25. Li JY, Wu Y, Xu MY. Alteplase thrombolytic therapy of 63 cases with ultra-early cerebral infarction. J Chin Physician. 2008;10:1412-3.
26. Zhan YH. Study on the treatment of intravenous and intraarterial thrombolysis with rt-PA in patients with acute cerebral infarction under the guide of Multimodal MRI [dissertation]. Fuzhou: Fujian Medical University; 2009.
27. Zhang B. Thrombolysis for the acute ischemic stroke [dissertation]. Shanghai: Shanghai Jiaotong University; 2008.
28. Huang H, Yang Y, Pan XP, Cheng QS, Deng WH, Zhou J. Comparative study of treatment for acute cerebral infarction of internal carotid artery system with intraarterial and intravenous thrombolysis. Chin J Neuromed. 2010;7:711-4.
29. Shao ZQ, Jiao JS, Xue S, Gui DC. Clinical application of intravenous thrombolytic therapy of recombinant tissue plasminogen activator for super-early stage of cerebral infarction. Clin Med China. 2006;10:873-5.
30. Jauch EC, Saver JL, Adams HP, Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
31. Arboix A, Garcia-Eroles L, Massons J, Oliveres M, Targa C. Acute stroke in very old people: clinical features and predictors of in-hospital mortality. J Am Geriatr Soc. 2000;48:36-41.
32. Jiang Y, Li XY, Hu N, Huang ZJ, Wu F. [Epidemiologic characteristics of cerebrovascular disease mortality in China, 2004-2005]. Zhonghua Yu Fang Yi Xue Za Zhi. 2010;44:293-7.
33. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6:456-64.
34. Wang YL, Wu D, Liao X, Zhang W, Zhao X, Wang YJ. Burden of stroke in China. Int J Stroke. 2007;2:211-3.
35. Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011;42:3651-4.
36. Wardlaw JM, Murray V, Berge E, Del ZGJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2009;(4):CD000213.
37. Lees KR, Bluhmki E, von KR, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-703.